CellCentric is a biotechnology company focused on developing innovative cancer therapies. Their lead product, Inobrodib (CCS1477), is a first-in-class p300/CBP inhibitor drug designed to target specific cancers by disrupting the growth of cancer cells....
Phone
+44 1799 531130
